Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate added to early goal-directed therapy for severe sepsis and septic shock
IRCT20220310054246N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sodium bicarbonate in sepsis and septic shock (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Hemodynamic parameters and Gasometric parameters. Started May 2023; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on IRCT20220310054246N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220310054246N1.